These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9892993

  • 1. Targeting tumors with iodine-123 labeled deoxyuridine: distribution and DNA binding.
    Thakur ML, Li J, Kim SM, Zhang JJ, Andrews D.
    Cancer Detect Prev; 1999; 23(1):72-7. PubMed ID: 9892993
    [Abstract] [Full Text] [Related]

  • 2. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES, Wang K, Adelstein SJ, Kassis AI.
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [Abstract] [Full Text] [Related]

  • 3. Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
    Macapinlac HA, Kemeny N, Daghighian F, Finn R, Zhang J, Humm J, Squire O, Larson SM.
    J Nucl Med; 1996 Apr; 37(4 Suppl):25S-29S. PubMed ID: 8676200
    [Abstract] [Full Text] [Related]

  • 4. Bystander effect produced by radiolabeled tumor cells in vivo.
    Xue LY, Butler NJ, Makrigiorgos GM, Adelstein SJ, Kassis AI.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13765-70. PubMed ID: 12368480
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI, Adelstein SJ, Mariani G.
    Q J Nucl Med; 1996 Sep 15; 40(3):301-19. PubMed ID: 8961807
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Biochemical modulation by 5-fluorouracil and 1-folinic acid of tumor uptake of intra-arterial 5-[123I]iodo-2'deoxyuridine in patients with liver metastases from colorectal cancer.
    Mariani G, Di Sacco S, Bonini R, Di Luca L, Buralli S, Bonora D, Ricci S, Baranowska-Kortylewicz J, Adelstein SJ, Falcone A, Kassis AI.
    Acta Oncol; 1996 Sep 15; 35(7):941-5. PubMed ID: 9004775
    [Abstract] [Full Text] [Related]

  • 9. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
    Kassis AI, Tumeh SS, Wen PY, Baranowska-Kortylewicz J, Van den Abbeele AD, Zimmerman RE, Carvalho PA, Garada BM, DeSisto WC, Bailey NO, Castronovo FP, Mariani G, Black PM, Adelstein SJ.
    J Nucl Med; 1996 Apr 15; 37(4 Suppl):19S-22S. PubMed ID: 8676198
    [Abstract] [Full Text] [Related]

  • 10. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
    Van den Abbeele AD, Tutrone RF, Berman RM, Baranowska-Kortylewicz J, Barclay PD, Richie JP, Adelstein SJ, Kassis AI.
    J Nucl Med; 1996 Feb 15; 37(2):315-20. PubMed ID: 8667069
    [Abstract] [Full Text] [Related]

  • 11. 5-[125]iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats.
    Kassis AI, Adelstein SJ.
    Acta Oncol; 1996 Feb 15; 35(7):935-9. PubMed ID: 9004774
    [Abstract] [Full Text] [Related]

  • 12. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM, Vazquez M, Mach JP, De Tribolet N, Pichard C, Slosman DO, Buchegger F.
    Cancer Res; 2001 Nov 01; 61(21):7971-7. PubMed ID: 11691821
    [Abstract] [Full Text] [Related]

  • 13. Tumor uptake and mitotic activity pattern of 5-[125I]iodo-2'- deoxyuridine after intravesical infusion in patients with bladder cancer.
    Mariani G, Collecchi P, Baldassarri S, Di Luca L, Buralli S, Fontanini G, Baranowska-Kortylewicz J, Adelstein SJ, Kassis AI.
    J Nucl Med; 1996 Apr 01; 37(4 Suppl):16S-19S. PubMed ID: 8676197
    [Abstract] [Full Text] [Related]

  • 14. Radiosynthesis, in vitro cellular uptake and in vivo biodistribution of 3'-O-(3-benzenesulfonylfuroxan-4-yl)-5-[125I]iodo-2'-deoxyuridine, a nucleoside-based nitric oxide donor.
    Moharram S, Zhou A, Kumar P, Knaus EE, Wiebe LI.
    Nucl Med Biol; 2005 Aug 01; 32(6):641-5. PubMed ID: 16026711
    [Abstract] [Full Text] [Related]

  • 15. 5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.
    Vaidyanathan G, Larsen RH, Zalutsky MR.
    Cancer Res; 1996 Mar 15; 56(6):1204-9. PubMed ID: 8640798
    [Abstract] [Full Text] [Related]

  • 16. [Study on biodistribution and imaging of radioiodinated antisense oligonucleotides in nude mice bearing human lymphoma].
    Shen J, Wang RF, Zhang CL, Liu M, Guo FQ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec 15; 36(6):655-9. PubMed ID: 15605104
    [Abstract] [Full Text] [Related]

  • 17. In vivo studies of unlabeled and radioiodinated rhodamine-123.
    Vora MM, Dhalla M.
    Int J Rad Appl Instrum B; 1992 Apr 15; 19(3):405-10. PubMed ID: 1629029
    [Abstract] [Full Text] [Related]

  • 18. Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
    Lee FT, Hall C, Rigopoulos A, Zweit J, Pathmaraj K, O'Keefe GJ, Smyth FE, Welt S, Old LJ, Scott AM.
    J Nucl Med; 2001 May 15; 42(5):764-9. PubMed ID: 11337573
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
    Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M.
    J Nucl Med; 2001 Feb 15; 42(2):326-36. PubMed ID: 11216533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.